Desiree E. Doncals

722 total citations
12 papers, 99 citations indexed

About

Desiree E. Doncals is a scholar working on Obstetrics and Gynecology, Surgery and Oncology. According to data from OpenAlex, Desiree E. Doncals has authored 12 papers receiving a total of 99 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Obstetrics and Gynecology, 5 papers in Surgery and 4 papers in Oncology. Recurrent topics in Desiree E. Doncals's work include Endometrial and Cervical Cancer Treatments (6 papers), Colorectal and Anal Carcinomas (4 papers) and Cervical Cancer and HPV Research (3 papers). Desiree E. Doncals is often cited by papers focused on Endometrial and Cervical Cancer Treatments (6 papers), Colorectal and Anal Carcinomas (4 papers) and Cervical Cancer and HPV Research (3 papers). Desiree E. Doncals collaborates with scholars based in United States, Canada and South Korea. Desiree E. Doncals's co-authors include Yuhchyau Chen, Douglas Johnson, Samir Narayan, Tracey E. Schefter, Jeff M. Michalski, Barbara Fisher, Albert J. Chang, Christopher H. Crane, Deborah Watkins Bruner and André Abitbol and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Gynecologic Oncology.

In The Last Decade

Desiree E. Doncals

12 papers receiving 97 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Desiree E. Doncals United States 5 65 39 29 24 23 12 99
C.L. Ferguson United States 5 32 0.5× 32 0.8× 28 1.0× 18 0.8× 27 1.2× 14 89
Spencer Thompson United States 6 48 0.7× 32 0.8× 18 0.6× 20 0.8× 20 0.9× 15 106
Marie-Eve Chand-Fouché France 6 50 0.8× 50 1.3× 26 0.9× 19 0.8× 12 0.5× 13 103
Laura Motisi Germany 4 43 0.7× 43 1.1× 14 0.5× 17 0.7× 15 0.7× 9 70
K. De Winter Netherlands 5 37 0.6× 73 1.9× 12 0.4× 21 0.9× 32 1.4× 5 109
Dina Najjari-Jamal Spain 5 39 0.6× 31 0.8× 11 0.4× 13 0.5× 17 0.7× 13 72
Sara Zakem United States 5 31 0.5× 12 0.3× 40 1.4× 7 0.3× 24 1.0× 12 78
Karen Nkiwane Austria 7 65 1.0× 88 2.3× 19 0.7× 14 0.6× 12 0.5× 8 112
Marit Sundset Norway 4 52 0.8× 88 2.3× 12 0.4× 14 0.6× 6 0.3× 7 109
M. Panadés United Kingdom 5 21 0.3× 26 0.7× 22 0.8× 19 0.8× 18 0.8× 7 60

Countries citing papers authored by Desiree E. Doncals

Since Specialization
Citations

This map shows the geographic impact of Desiree E. Doncals's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Desiree E. Doncals with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Desiree E. Doncals more than expected).

Fields of papers citing papers by Desiree E. Doncals

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Desiree E. Doncals. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Desiree E. Doncals. The network helps show where Desiree E. Doncals may publish in the future.

Co-authorship network of co-authors of Desiree E. Doncals

This figure shows the co-authorship network connecting the top 25 collaborators of Desiree E. Doncals. A scholar is included among the top collaborators of Desiree E. Doncals based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Desiree E. Doncals. Desiree E. Doncals is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Corrigan, Kelsey L., Rebecca Paulus, Ann H. Klopp, et al.. (2025). Patient-Reported Outcomes During Pelvic Radiation Therapy: A Secondary Analysis on Sexual Function From NRG-RTOG 1203. PubMed. 2(2). e2400088–e2400088. 2 indexed citations
2.
Michalski, Jeff M., Jennifer Moughan, James A. Purdy, et al.. (2023). Long-Term Outcomes of NRG/RTOG 0126, a Randomized Trial of High Dose (79.2 Gy) vs. Standard Dose (70.2 Gy) Radiation Therapy (RT) for Men with Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 117(2). S4–S5. 3 indexed citations
3.
Konski, André, Snehal Deshmukh, Ann H. Klopp, et al.. (2023). Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203. Gynecologic Oncology. 175. 176–181. 1 indexed citations
4.
Corrigan, Kelsey L., Rebecca Paulus, Ann H. Klopp, et al.. (2023). Patient-reported outcomes during pelvic radiation therapy: A secondary analysis on sexual function from NRG-RTOG 1203.. Journal of Clinical Oncology. 41(16_suppl). 5533–5533. 1 indexed citations
5.
Spratt, Daniel E., Huei–Chung Huang, Jeff M. Michalski, et al.. (2022). Validation of the performance of the Decipher biopsy genomic classifier in intermediate-risk prostate cancer on the phase III randomized trial NRG Oncology/RTOG 0126.. Journal of Clinical Oncology. 40(6_suppl). 269–269. 4 indexed citations
6.
Yeung, Anamaria R., Ann H. Klopp, Krzysztof Gil, et al.. (2019). IMRT Improves Late Toxicity Compared to Conventional RT: An Update on NRG Oncology-RTOG 1203. International Journal of Radiation Oncology*Biology*Physics. 105(1). S50–S50. 10 indexed citations
7.
Olsen, Jeffrey R., Jennifer Moughan, Robert J. Myerson, et al.. (2017). Predictors of Radiation Therapy–Related Gastrointestinal Toxicity From Anal Cancer Dose-Painted Intensity Modulated Radiation Therapy: Secondary Analysis of NRG Oncology RTOG 0529. International Journal of Radiation Oncology*Biology*Physics. 98(2). 400–408. 36 indexed citations
8.
Klopp, Ann H., Anamaria R. Yeung, Krzysztof Gil, et al.. (2016). A Phase III Randomized Trial Comparing Patient-Reported Toxicity and Quality of Life (QOL) During Pelvic Intensity Modulated Radiation Therapy as Compared to Conventional Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 96(2). S3–S3. 27 indexed citations
9.
Machtay, Mitchell, Diáne Hershock, Robert A. Lustig, et al.. (2012). Long-term Outcomes from RTOG 99-03: Radiation Therapy With or Without Erythropoietin for Anemic Head-and-Neck Cancer Patients. International Journal of Radiation Oncology*Biology*Physics. 84(3). S21–S21. 1 indexed citations
10.
Bruner, Deborah Watkins, William F. Hartsell, André Konski, et al.. (2004). Prospective health-related quality of life valuations (utilities) of 8 Gy in 1 fraction vs 30 Gy in 10 fractions for palliation of painful bone metastases: Preliminary results of RTOG 97–14. International Journal of Radiation Oncology*Biology*Physics. 60(1). S142–S142. 10 indexed citations
11.
Grigsby, Perry W., Kathryn Winter, Ritsuko Komaki, et al.. (2002). Long-term follow-up of RTOG 88-05: twice-daily external irradiation with brachytherapy for carcinoma of the cervix. International Journal of Radiation Oncology*Biology*Physics. 54(1). 51–57. 3 indexed citations
12.
Grigsby, Perry W., R. Komaki, Patricia J. Eifel, et al.. (2001). Long-term follow-up of RTOG 88-05: twice-daily external irradiation with brachytherapy for carcinoma of the cervix. International Journal of Radiation Oncology*Biology*Physics. 51(3). 62–62. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026